Amanda J Hooper Selected Research

Hypobetalipoproteinemias (Hypobetalipoproteinemia)

6/2016	Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.
5/2016	Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia.
11/2015	Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
11/2015	Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia.
7/2014	Update on primary hypobetalipoproteinemia.
4/2008	Familial hypobetalipoproteinemia in a Turkish family with hereditary spastic paraplegia.
8/2007	Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
4/2007	Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
7/2006	Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda J Hooper Research Topics

Disease

13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2011
12	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 08/2007
9	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 06/2016 - 07/2006
8	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 03/2008
8	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2005
8	Hypercholesterolemia 01/2018 - 01/2011
7	Atherosclerosis 01/2020 - 01/2005
4	Hypertension (High Blood Pressure) 07/2022 - 03/2015
4	Pancreatitis 03/2020 - 12/2009
4	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 11/2015 - 07/2006
3	Insulin Resistance 01/2022 - 07/2014
3	Homozygous Familial Hypercholesterolemia 10/2018 - 02/2011
3	Inborn Genetic Diseases (Disease, Hereditary) 05/2016 - 09/2009
3	Xanthomatosis (Xanthoma) 12/2009 - 02/2008
2	Obesity 07/2022 - 12/2015
2	Tangier Disease 01/2020 - 11/2009
2	Wolman Disease (Wolman's Disease) 01/2018 - 12/2008
2	Hypothyroidism 04/2017 - 11/2006
2	Dyslipidemias (Dyslipidemia) 01/2015 - 01/2012
2	Hyperlipidemias (Hyperlipidemia) 01/2012 - 04/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2021
1	Rare Diseases (Rare Disease) 06/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Myocardial Infarction 10/2018
1	Genetic Risk Score 01/2018
1	Type E Brachydactyly 04/2017
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 11/2016
1	Renal Insufficiency (Renal Failure) 12/2015
1	Failure to Thrive 11/2015
1	Steatorrhea 11/2015
1	Phenylketonurias (Phenylketonuria) 02/2015
1	Type B Niemann-Pick Disease 09/2014
1	Hypersplenism (Anemia, Splenic) 09/2014
1	Fibrosis (Cirrhosis) 06/2013
1	Alcoholic Fatty Liver 06/2013
1	Injection Site Reaction 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010
1	Lipoma (Lipomata) 01/2010
1	Abdominal Pain (Pain, Abdominal) 12/2009
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 12/2009
1	Hypertriglyceridemia 12/2009
1	Histiocytosis 11/2009
1	Hemorrhage 11/2009
1	Infections 09/2009

Drug/Important Bio-Agent (IBA)

26	LDL CholesterolIBA 01/2021 - 07/2006
16	Apolipoproteins B (ApoB)IBA 01/2021 - 01/2005
13	ApolipoproteinsIBA 01/2021 - 07/2006
12	LDL Lipoproteins (beta Lipoproteins)IBA 08/2016 - 04/2008
12	Lipoproteins (Lipoprotein)IBA 06/2016 - 01/2005
11	LipidsIBA 02/2021 - 11/2009
8	Lipoprotein(a)IBA 07/2022 - 02/2011
8	CholesterolIBA 12/2020 - 11/2009
7	oxidized low density lipoproteinIBA 01/2021 - 02/2008
5	HDL CholesterolIBA 02/2019 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2015 - 02/2011
3	LDL Receptors (LDL Receptor)IBA 07/2022 - 06/2014
3	Triglycerides (Triacylglycerol)IBA 04/2022 - 03/2008
3	Proprotein Convertase 9IBA 01/2021 - 08/2007
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2020 - 12/2009
3	Apolipoprotein B-100 (Apo B 100)IBA 01/2011 - 08/2007
2	CalciumIBA 01/2020 - 01/2020
2	Vitamin E FDA LinkGeneric 11/2015 - 07/2006
2	Phenylalanine (L-Phenylalanine)FDA Link 02/2015 - 05/2009
2	O(4)-methylthymidine triphosphateIBA 01/2015 - 10/2014
2	EnzymesIBA 09/2014 - 05/2009
2	mipomersenIBA 01/2012 - 02/2011
1	Fibronectins (Fibronectin)IBA 07/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Asparaginase (Elspar)FDA Link 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Sebelipase alfaIBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2017
1	CreatinineIBA 12/2015
1	Dietary Fats (Dietary Fat)IBA 11/2015
1	Retinaldehyde (Retinal)IBA 11/2015
1	VitaminsIBA 11/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 02/2015
1	BMS201038IBA 01/2015
1	VLDL LipoproteinsIBA 01/2015
1	microsomal triglyceride transfer proteinIBA 01/2015
1	ChylomicronsIBA 01/2015
1	AcidsIBA 09/2014
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 09/2014
1	neodymium pyrocatechin disulfonate (NPD)IBA 09/2014
1	AngiopoietinsIBA 07/2014
1	anacetrapibIBA 01/2012
1	A-Form DNA (A-DNA)IBA 01/2011
1	Antihypertensive Agents (Antihypertensives)IBA 01/2010
1	Cholesterol Esters (Cholesteryl Esters)IBA 11/2009
1	Nonsense Codon (Nonsense Mutation)IBA 11/2009
1	Transaminases (Aminotransferases)IBA 09/2009

Therapy/Procedure

11	Therapeutics 02/2021 - 01/2010
1	Plasma Exchange 03/2020
1	Enzyme Replacement Therapy 01/2018
1	Blood Component Removal (Apheresis) 06/2014